Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
Journal article published in 2018 by
Anna Wenger,
Katja Werlenius 
,
Alexander Hallner,
Fredrik Bergh Thorén,
Dan Farahmand,
Magnus Tisell,
Anja Smits,
Bertil Rydenhag,
Asgeir S. Jakola,
Helena Carén
,
Alexander Hallner,
Fredrik Bergh Thorén,
Dan Farahmand,
Magnus Tisell,
Anja Smits,
Bertil Rydenhag,
Asgeir S. Jakola,
Helena Carén
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 